Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (May 2025)
51 slides from Burjeel's investor presentation, May 2025
Slide 1: Burjeel Holdings: Leading Super-Specialty Healthcare Provider in MENA
May 2025 Burjeel Holdings Leading Super-Specialty Healthcare Provider in MENA
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 02 03 Investment Strategic Case Priorities 01 Burjeel Holdings at a Glance 04 Performance Update 06 05 Appendix Guidance
Slide 4: Burjeel Holdings at a Glance
01 Burjeel Holdings at a Glance Leading Super-Specialty Healthcare Provider in MENA
Slide 5: Leading Integrated Healthcare Network in the MENA
Leading Integrated Healthcare Network in the MENA Expanding market presence UAE, Oman & KSA 110 19% Geographical Medical assets Inpatient market presence incl. 20 hospitals1 share in the UAE2 1,743 6.5 million 1,777 Bed capacity3 Total patients4 Doctors3 Diversified portfolio of brands AAA ESG MSCI
Slide 6: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Hospital Medical Centers 1% Pharmacies Physiotherapy 87% Dubai & 9% 88% centers Northern 1% Other Emirates Abu Dhabi, Hospitals Al Dhafra & Al Ain 10% Medical Centers 4% Om
Slide 7: Business model
1 2 Business 1 Differentiating capabilities model • Level I & II Trauma Center • Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 8: Transforming Cancer Care: The UAE's Leading National Network
5 Expanding geographically Transforming Cancer Care: The UAE’s Leading National Network Burjeel Cancer Institute Diversified Referral Pathways Clinical Governance (Burjeel Medical City) Strengthening Oncology Access & Research Hub for high-end specialized oncology treatments Pathology, AI & Molecula
Slide 9: Advancing Women & Children's Healthcare Offering
Advancing Women & Children’s Healthcare Offering Partnered with the "Father of Fetal The UAE’s largest fertility center, Medicine," to provide fetal care for high- which commenced operations in risk pregnancies. First in MENA to September 2024 and became fully perform in-utero spina bifida repair. o
Slide 10: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in MENA
Slide 11: Strategic priorities: Ramp-up, Operational Excellence, Complex Care, KSA
5 Expanding geographically Ramp-up of Growth Assets Operational Excellence • Use young asset fleet to drive • Invest in clinical and nursing volume through enhanced utilization teams to enhance patient care • Position Burjeel Medical City • Lead in medical education as a primary growth driver and gl
Slide 12: Strategic Growth Pillars
5 Expanding geographically Strategic Growth Pillars Ramp-up of Growth Assets Increasing Patient Yield Operational Excellence Geographic Expansion Group Revenue Patient Yield Group EBITDA Margin Revenue from UAE Expansion Single 5,010 12%-14% Mid-Term Mid-Term Mid-Term ‘24 ‘24 754 Digit ‘24 19% 25%-2
Slide 13: Investment Case
03 Investment Case Leading Super-Specialty Healthcare Provider in MENA
Slide 14: Investment case highlights
World-class super- Expanding geographically specialty care through high-return and offering driving patient low-CAPEX opportunities yield growth Accelerating Leading position in large, growing & digitization resilient market to drive operational and medical excellence Well-invested multi- Cash-gener
Slide 15: Differentiated Growth Strategy to Drive Complex Care Across UAE Network
1 World-class super-specialty care Differentiated Growth Strategy to Drive Complex Care Across Burjeel’s UAE Network DSCs optimize Burjeel Hospitals’ bed capacity Burjeel BMC Complex for complex care, with over 60% of elective 6 Hospitals 400 Care Beds surgeries feasible as same-day procedures Burje
Slide 16: Super-Specialty Care Offering Driving Patient Yields
51 World-classgeographically Expanding super-specialty care Super-Specialty Care Offering Driving Patient Yields Unmatched Da Vinci Xi system Momentum in Scaling Maximizing Patient Growth & Yield Innovation & Expertise Multi-Organ & Bone Marrow Transplants Liver & Kidney Transplants 50 (100% success
Slide 17: Robust Talent Investments Powering Innovation & Research Capabilities
1 World-class super-specialty care Robust Talent Investments Powering Innovation & Research Capabilities Highly skilled and growing talent pool UAE’s Premier Research Hub: Advancing Science & Innovation +831 Doctors Axiom Space Partnership: Exploring microgravity’s role in disease understanding, dru
Slide 18: UAE Market Leader with a Prominent Position Across Segments
2 Leading position UAE Market Leader with a Prominent Position Across Segments Number of beds by key players1, as of December 2022 #1 inpatient platform in the UAE by private market volumes Beds excl. LTC in UAE 1,660 3 135 1,361 Beds in Oman 1,161 1,077 1,071 300 Focus on specialised and complex LT
Slide 19: Large, Growing and Resilient Addressable Market
2 Leading position Large, Growing and Resilient Addressable Market FY 2022 UAE & Oman & KSA market size1 $104bn Total healthcare expenditure (USD bn) 132 GCC market size2 112 $85bn UAE & Oman & KSA market size1 85 93 1.9x $27bn 69 UAE & Oman market size1 $1.4bn Burjeel Holdings revenue (FY 2024) 202
Slide 20: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception to FY'24 AED 4.7bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints – driving reven
Slide 21: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Diverse brand portfolio and network Brands creates favourable negotiating position with insurance payers 12 Hospitals2 Insurance payers are the largest revenue 4 Hospitals 2 Hospitals Assets1 9 Medical
Slide 22: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset maturity split for hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 37% Growth – high FY 2024 Mature Burjeel Hospital, Abu Dhabi High-Growth Burjeel Me
Slide 23: Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential
5 Expanding geographically Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential Key region of focus – UAE & KSA Expansion strategy pillars Expanding World-Class Healthcare Network KSA to drive our geographic expansion 1 Across Emerging UAE Communities Zero-capex expansion into Africa, thr
Slide 24: Expanding Reach, Enhancing Care: Burjeel's Growth Plan across the UAE
5 Expanding geographically Expanding Reach, Enhancing Care: Burjeel’s Growth Plan across the UAE Launch of 1 hospital, The Group will expand its Burjeel-branded network with a hospital, a day surgery center in 1 day surgery center, 11 specialized Dubai and the Northern Emirates, and 11 specialized m
Slide 25: PhysioTherabia – Entering High Potential KSA Market
5 Expanding geographically PhysioTherabia – Entering High Potential KSA Market Highly attractive entry proposition Launched first premier physiotherapy centers 60 + Physical therapy, rehabilitation and wellness centers in 12 KSA cities in a joint venture (50:50) with Leejam Company 29 centers Physio
Slide 26: Specialized Day Surgery Centers – Disruptive Innovation in Saudi Healthcare Market
5 Expanding geographically Specialized Day Surgery Centers – Disruptive Innovation in Saudi Healthcare Market Strong rationale for expansion in KSA Burjeel One – First Day Surgery Center in Riyadh • Promising macro and demographic trends o GDP growth of c.5.5% p.a. • Located in Irqah, Northwestern R
Slide 27: Ongoing Expansion of Asset-Light O&M Portfolio Drives Bottom-Line Growth
5 Expanding geographically Ongoing Expansion of Asset-Light O&M Portfolio Drives Bottom-Line Growth O&M opportunities in the UAE and MENA 2024 O&M projects FY’24 Al • Stakeholder: ADNOC Group (Corporate) 188,000+ Approach Dhannah • Specifications: Multi-specialty hospital in Al Dhafrah, Abu Dhabi Pa
Slide 28: Leveraging Digital Transformation to Enhance Patient Experience
6 Accelerating digitization Leveraging Digital Transformation to Enhance Patient Experience and Maximise Operational Efficiency Strategic digital initiatives Key digital achievements Patient digital channel • Mid-term key investment areas in Digital Health Mobile application • Oracle Health informat
Slide 29: Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics
6 Accelerating digitization Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics AI-Driven Eligibility Engine AI Dashboard Capabilities Denial reduction ICD Validation Prevents denial root causes and ensures Reads and analyses ICDs in the claim compliance with guidelines and reg
Slide 30: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 31: Strong Leadership with Well-Established Public Market-Oriented Corporate Governance
8 Commitment to ESG Strong Leadership with Well-Established Public Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A N B A A N 1 Female Board B Business Development & Director Sustaina
Slide 32: Strategic Pillars – ESG Framework
8 Commitment to ESG Strategic Pillars – ESG Framework System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives per year by 2026 1 Maintain a h
Slide 33: FY 2024 ESG Highlights
8 Commitment to ESG FY 2024 ESG Highlights System Community Governance Environment 95% 87% Zero -29% Employee Inpatient Data breaches, corruption or GHG satisfaction score satisfaction score bribery and whistleblowing cases emission 54% 100% 100% -35% Women in Healthcare staff completed Hospitals in
Slide 34: Performance Update
04 Performance Update Leading Super-Specialty Healthcare Provider in MENA
Slide 35: Q1'25 Results: Key Learnings & Strategic Responses
5 Expanding geographically Q1’25 Results: Key Learnings & Strategic Responses Q1’25 Financial Areas of Pressure Root Causes & Context Strategic Response Results Patient Footfall Drop in • Ramadan impact was • Refine planning assumptions and scale underestimated and more appointment capacity in Q2 to
Slide 36: Q1'25 Group Patient Footfall Trends
Q1’25 Group Patient Footfall Trends Group Inpatient Footfall, k Group Outpatient Footfall, k +11.4% • Jan–Feb’25 accounted for 86% of the +5.2% • Outpatient footfall in Jan–Feb’25 rose 7.9% incremental growth in Q1 inpatient footfall, YoY, driven by the continued ramp-up of key 43 driven by the ramp
Slide 37: Revenue & EBITDA Analysis Across Key Business Segments
Revenue & EBITDA Analysis Across Key Business Segments Group Revenue, AED m Segment-Wise Revenue & EBITDA, AED m • Top-line growth in Jan–Feb’25 rose 14.5% YoY, +101 1,375 • Hospital revenue grew 3.6% +5.7% supported by strong patient footfall growth YoY to AED 1,126 million. (+8.0% YoY), healthy su
Slide 38: Burjeel Medical City Performance
5 Expanding geographically Burjeel Medical City Performance Total Patients, k Revenue, AED m1 EBITDA, AED m1 +14.7% +11.2% 141 +20.4% +17.8% 315 123 +20.3% 283 100 226 53 83 192 44 Jan - Feb'24 Jan - Feb'25 Q1'24 Q1'25 Jan - Feb'24 Jan - Feb'25 Q1'24 Q1'25 Q1'24 Q1'25 • Burjeel Medical City (BMC) de
Slide 39: Operating Cost Trends & EBITDA Variance Analysis
Operating Cost Trends & EBITDA Variance Analysis Group OPEX Breakdown,1 AED and % of Revenue Group EBITDA Analysis,2 AED m 1,102 1,098 84.4% 86.2% 963 79.9% +69 (58) 168 157 +101 (22) 111 28 39 12.8% 12.3% +1 261 9.2% 2.2% 3.0% 234 (16) 22 1.8% (15) (45) 328 316 24.8% 302 25.0% 25.2% +12 181 (22.9%)
Slide 40: Cash Flow & Profitability Performance
Cash Flow & Profitability Performance Cash Flow from Operating Activities, AED m Group Net Profit Analysis, AED m 566 +69 (135) 500 358 104 328 142 +12 (9) 115 (8) +6 39 2021 2022 2023 2024 Q1’24 Q1’25 Q1’24 Q1'24 Revenue Revenue OPEX OPEX Change Change… D&A Finance D&A Finance costs Taxes Taxes Q1’
Slide 41: Capital Structure & Leverage Overview
Capital Structure & Leverage Overview AED m FY 2023 FY 2024 Q1’25 Debt Maturity as of 31 March 2025 Bank balances and cash 170 238 270 Interest-bearing loans and borrowings 1,164 1,208 1,341 243 237 204 214 Bank overdrafts – -- -- 201 Bank debt1 1,164 1,208 1,341 131 Net debt 994 970 1,071 110 Lease
Slide 42: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in MENA
Slide 43: FY2025 Guidance Under Review, Mid-Term Confidence Intact
FY2025 Guidance Under Review, Mid-Term Confidence Intact FY 2025 (Expected) Mid-term (2026-2028) • UAE: 1 advanced care oncology center (Dubai), 1 • UAE: 1 hospital (Dubai), 1 day surgery center (Ras Al-Khaimah), 3 Expansion fertility clinic (Al Ain), 6 medical center medical center • KSA: 31 Physio
Slide 44: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in MENA
Slide 45: Track-record of Consistent Growth
Track-record of Consistent Growth 2007-2010 2015 2017 2019 2021 2023 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East Clinic, in 2007 under LLH Launch invasive surgeries and alternative Burjeel Hospital capabiliti
Slide 46: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘22-31E of GDP1 Healthcare expenditure as % of GDP1 +1.9% +31.9% +4% +3% +3% 4-5% 12% 19% CAGR ‘22-27E CAGR ‘22-27E of GCC UAE Oman K
Slide 47: Main Trends in Organ Transplant and Oncology Specialties in the UAE
Main Trends in Organ Transplant and Oncology Specialties in the UAE Organ transplant Oncology Total number of organ transplants performed in the UAE Total number of malignant cancer cases in UAE (k) CAGR 17-22 CAGR 2011-2022 5.0 Living 213 4.6 4.7 4.8 4.9 Deceased 184 16% 7.3% 4.0 4.1 71 3.6 3.6 3.7
Slide 48: Healthcare is a Key Focus for GCC Governments
Healthcare is a Key Focus for GCC Governments UAE initiatives Oman Health Vision 2050 KSA Vision 2030 UAE Vision 2021 To achieve sustainable funding for Some of the key initiatives health research by ensuring national in the healthcare spectrum: Providing world-class healthcare and international col
Slide 49: FY 2023-2024 Group & Segment Summary
FY 2023-2024 Group & Segment Summary Group financial summary Segmental financial summary2 AED millions FY’24 FY‘23 AED millions FY’24 FY‘23 Revenue 5,010 4,535 Revenue 5,010 4,535 Inventories consumed (1,269) (1,096) Hospitals3 4,406 4,026 Doctors’ and other employees’ salaries (2,186) (1,947) Medic
Slide 50: Q1 2024-2025 Group & Segment Summary
Q1 2024-2025 Group & Segment Summary Group financial summary Segmental financial summary AED millions Q1’25 Q1’24 AED millions Q1’25 Q1’24 Revenue 1,274 1,205 Revenue 1,274 1,205 Inventories consumed (316) (302) Hospitals1 1,126 1,087 Medical Centers1 108 92 Doctors’ and other employees’ salaries (5
Slide 51: IR Contacts
IR Contacts May 2025 Sergei Levitskii Director of Investor Relations sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 ir@burjeelholdings.com F: +971 2 2222 363 M: +971 503802383 PO Box 7400, Abu Dhabi, UAE Investor Calendar Company Website